Research Project · Health

2027 Lotus Award for Ovarian Cancer Research

pershingsquarephilanthropies.org (opens in a new tab)Catalog updated

Deadline Letter of intent
Amount
$750,000
Program type
Research Project
Field
Health
Eligible career stages
Not listed

About this program

The Pershing Square Foundation’s 2027 Lotus Award supports radically innovative, high-risk/high-reward research with potential to transform the understanding, early detection, prevention, or treatment of ovarian cancer. Each award provides $250,000 annually for three years, totaling $750,000, and requires only a letter of intent, biosketch, and budget, due February 1, 2027, at 5:00 p.m. ET. Applicants must hold a PhD, MD, or equivalent; lead principal investigators must have a tenure-track faculty appointment at a U.S. academic research institution and at least two years of independent laboratory experience by August 2027. Investigators without ovarian cancer research experience must include an eligible ovarian cancer collaborator, and applicants may participate in only one PSF prize program during the cycle.

In FundFit

FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 50 or more similar programs in full.

Ask for a demo of this program The form opens already filled in.

Full eligibility

Source announcement

Similar programs